Market Overview

Benzinga's Top Pre-Market Gainers

Related VRX
UPDATE: Valeant Pharmaceuticals Posts Higher Q2 Profit
Earnings Scheduled For July 31, 2014
Allergan Rebuffs Valeant's Tender Offer (Fox Business)
Related MRX
Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
Medicis Pharmaceutical Spikes Higher on 8-K Filing Regarding Dismissed Lawsuit

Medicis Pharmaceutical (NYSE: MRX)) soared 37.67% to $43.45 in the pre-market trading. Valeant Pharmaceuticals International (NYSE: VRX) announced its plans to acquire Medicis Pharmaceutical for $2.6 billion in cash.

StemCells (NASDAQ: STEM) added 17.51% to $2.55 in the pre-market session. StemCells reported positive interim six-month data from spinal cord injury trial.

Questcor Pharmaceuticals (NASDAQ: QCOR) surged 10.66% to $48.07 in the pre-market session. Questcor's PEG ratio is 0.42.

Campbell Soup Co (NYSE: CPB) moved up 9.22% to $38.38 in the pre-market session. Campbell Soup reported a rise in its Q4 profit.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Most Popular

Related Articles (CPB + MRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters